Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: Implications for the neuropharmacology of cognitive deficitsin schizophrenia

Neuropsychopharmacology

Volumn 28, Issue 1, 2003, Pages 170-181

  Umbricht, Daniel ^a   Vollenweider, Franz X ^a   Schmid, Liselotte ^a   Grübel, Claudia ^b   Skrabo, Anja ^b   Huber, Theo ^a   Koller, Rene ^a  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Cognition; Mismatch negativity; Modelpsychosis; Psilocybin; Schizophrenia; Serotonin; Working memory

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PSILOCYBINE; SEROTONIN 2A RECEPTOR; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

ADULT; ARTICLE; COGNITIVE DEFECT; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; EVOKED AUDITORY RESPONSE; EVOKED RESPONSE; FEMALE; HUMAN; MALE; ORIENTATION; PERCEPTIVE DISCRIMINATION; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE;

ADULT; COGNITION DISORDERS; DISCRIMINATION (PSYCHOLOGY); ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MALE; ORIENTATION; PSILOCYBINE; PSYCHOMOTOR PERFORMANCE; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SEROTONIN; SCHIZOPHRENIC PSYCHOLOGY; SEROTONIN AGONISTS;

EID: 0037209132     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/sj.npp.1300005     Document Type: Article

References (106)

1. Adams B, Moghaddam B (1998).Corticolimbic dopamine neuro-transmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.J Neurosci18: 5545-5554.
2. Aghajanian GK, Marek GJ (1999a). Serotonin and hallucinogens.Neuropsychopharmacology21: 16S-23S.
3. Aghajanian GK, Marek GJ (1999b). Serotonin, via 5-HT2Areceptors, increases EPSCs in layer V pyramidal cells ofprefrontal cortex by an asynchronous mode of glutamate release.Brain Res825: 161-171.
4. Aghajanian GK, Marek GJ (2000). Serotonin model of schizo-phrenia: emerging role of glutamate mechanisms.Brain Res Brain Res Rev31: 302-312.
5. Alain C, Hargrave R, Woods DL (1998). Processing of auditory stimuli during visual attention in patients with schizophrenia.Biol Psychiatry44: 1151-1159.
6. Alain C, Woods DL, Ogawa KH (1994). Brain indices of automatic pattern processing.Neuroreport6: 140-144.
7. Alho K (1995). Cerebral generators of mismatch negativity (MMN) and its magnetic counterpart (MMNm) elicited by soundchanges.Ear Hear16: 38-51.
8. Anand A, Charney DS, Oren DA, Berman RM, Hu XS, Cappiello Aet al(2000). Attenuation of the neuropsychiatric effects ofketamine with lamotrigine: support for hyperglutamatergiceffects ofN-methyl-D-aspartate receptor antagonists.Arch GenPsychiatry57: 270-276.
9. Anand A, Charney DS, Oren DA, Berman RM, Hu XS, Cappiello A(1999). A pre-and postsynaptic modulatory action of 5-HT and the 5-HT2A 2Creceptor agonist DOB on NMDA-evoked responses in the ratmedial prefrontal cortex.Eur J Neurosci11: 2917-2934.
10. Barch DM, Carter CS, Braver TS, Sabb FW, MacDonald A, Noll DCet al(2001). Selective deficits in prefrontal cortex functionin medication-naive patients with schizophrenia.Arch GenPsychiatry58: 280-288.
11. Bilder RM (1997). Neurocognitive impairment in schizophrenia and how it affects treatment options.Can J Psychiatry42: 255-264.
12. Bilder RM (1998). The neuropsychology of schizophrenia: what, when, where, how? In: Fleischhacker WW, Hinterhuber H, MeiseU (eds).SchizophreneStorungen: State of the Art II, Ursachen-Behandlung-Verlauf.1st edn.Verlag Integrative Psychiatrie:Innsbruck, pp 155-171.
13. Bilder RM, Goldman RS, Robinson D, Reiter G, Bell L, Bates JA, Pappadopulos Eet al(2000). Neuropsychology of first-episodeschizophrenia: initial characterization and clinical correlates.Am J Psychiatry157: 549-559.
14. Breier A, Adler CM, Weisenfeld N, Su TP, Elman I, Picken Let al(1998). Effects of NMDA antagonism on striatal dopaminerelease in healthy subjects: application of a novel PET approach.Synapse29: 142-147.
15. Buchsbaum MS (1977). The middle evoked response components and schizophrenia.Schizophr Bull3: 93-104.
16. Catts SV, Shelley AM, Ward PB, Liebert B, McConaghy N, Andrews Set al(1995). Brain potential evidence for an auditory sensorymemory deficit in schizophrenia.Am J Psychiatry152: 213-219.
17. Chapman LJ, Chapman JP (1987). The measurement of handed-ness.Brain Cogn6: 175-183.
18. Cohen JD, Barch DM, Carter C, Servan-Schreiber D (1999). Context-processing deficits in schizophrenia: converging evidence from three theoretically motivated cognitive tasks.JAbnormPsychol108: 120-133.
19. Cornblatt BA, Keilp JG (1994). Impaired attention, genetics, and the pathophysiology of schizophrenia.Schizophr Bull20: 31-46.
20. Dehaene-Lambertz G (1997). Electrophysiological correlates of categorical phoneme perception in adults.Neuroreport8: 919-924.
21. Farber NB, Hanslick J, Kirby C, McWilliams L, Olney JW (1998). Serotonergic agents that activate 5HT2Areceptors preventNMDA antagonist neurotoxicity.Neuropsychopharmacology18:57-62.
22. Ford JM, White PM, Csernansky JG, Faustman WO, Roth WT, Pfefferbaum A (1994). ERPs in schizophrenia: effects ofantipsychotic medication.Biol Psychiatry36: 153-170.
23. Frodl-Bauch T, Kathmann N, Moller HJ, Hegerl U (1997). Dipole localization and test-retest reliability of frequency and durationmismatch negativity generator processes.Brain Topogr10: 3-8.
24. Geyer MA (1998). Behavioral studies of hallucinogenic drugs in animals: implications for schizophrenia research.Pharmacopsy-chiatry31(Suppl 2): 73-79.
25. Gottfries CG, von Knorring L, Perris C (1976). Neurophysiological measures related to levels of 5-hydroxyindoleacetic acid, homovanillic acid and tryptophan in cerebrospinal fluid ofpsychiatric patients.Neuropsychobiology2: 1-8.
26. Gouzoulis-Mayfrank E, Heekeren K, Thelen B, Lindenblatt H, Kovar KA, Sass Het al(1998). Effects of the hallucinogenpsilocybin on habituation and prepulse inhibition of the startlereflex in humans.BehavPharmacol9: 561-566.
27. Green MF (1996). What are the functional consequences of neurocognitive deficits in schizophrenia?Am J Psychiatry153:321-330.
28. Green MF, Marshall Jr BD, Wirshing WC, Ames D, Marder SR, McGurk S, Kern RS, Mintz J (1997). Does risperidone improveverbal working memory in treatment-resistant schizophrenia?.Am J Psychiatry154: 799-804.
29. Hasler F, Bourquin D, Brenneisen R, Bar T, Vollenweider FX (1997). Determination of psilocin and 4-hydroxyindole-3-aceticacid in plasma by HPLC-ECD and pharmacokinetic profiles oforal and intravenous psilocybin in man.PharmActaHelv72:175-184.
30. Hegerl U, Juckel G (1993). Intensity dependence of auditory evoked potentials as an indicator of central serotonergicneurotransmission: a new hypothesis.Biol Psychiatry33: 173-183.
31. Hegerl U, Juckel G (1994a). Auditory evoked dipole source activity: indicator of central serotonergic dysfunction in psychiatricpatients?Pharmacopsychiatry27: 75-78.
32. Hegerl U, Juckel G (1994b). Auditory evoked dipole source activity: indicator of central serotonergic dysfunction in psychiatricpatients?Pharmacopsychiatry27: 75-78.
33. Hegerl U, Lipperheide K, Juckel G, Schmidt LG, Rommelspacher H (1995). Antisocial tendencies and cortical sensory-evokedresponses in alcoholism.Alcohol ClinExp Res19: 31-36.
34. Hirayasu Y, Potts GF, O’Donnell BF, Kwon JS, Arakaki H, Akdag SJet al(1998). Auditory mismatch negativity in schizophrenia:topographic evaluation with a high-density recording montage.Am J Psychiatry155: 1281-1284.
35. Javitt DC, Doneshka P, Grochowski S, Ritter W (1995). Impaired mismatch negativity generation reflects widespread dysfunctionof working memory in schizophrenia.Arch Gen Psychiatry52:550-558.
36. Javitt DC, Doneshka P, Zylberman I, Ritter W, Vaughan Jr HG (1993). Impairment of early cortical processing in schizophrenia:an event-related potential confirmation study.Biol Psychiatry33:513-519.
37. Javitt DC, Liederman E, Cienfuegos A, Shelley AM (1999).Panmodal processing imprecision as a basis for dysfunction oftransient memory storage systems in schizophrenia.SchizophrBull25: 763-775.
38. Javitt DC, Schroeder CE, Steinschneider M, Arezzo JC, Vaughan Jr HG (1992).Demonstration of mismatch negativity in themonkey.ElectroencephalogrClinNeurophysiol83: 87-90.
39. Javitt DC, Shelley AM, Silipo G, Lieberman JA (2000). Deficits in auditory and visual context-dependent processing in schizo-phrenia: defining the pattern.Arch Gen Psychiatry57: 1131-1137.
40. Javitt DC, Steinschneider M, Schroeder CE, Arezzo JC (1996). Role of corticalN-methyl-D-aspartate receptors in auditory sensorymemory and mismatch negativity generation: implications forschizophrenia.ProcNatlAcadSciUSA 93: 11962-11967.
41. Javitt DC, Steinschneider M, Schroeder CE, Vaughan HG, Arezzo JC (1994). Detection of stimulus deviance within primateprimary auditory cortex: intracortical mechanisms of mismatchnegativity (MMN) generation.Brain Res667: 192-200.
42. Javitt DC, Strous RD, Grochowski S, Ritter W, Cowan N (1997). Impaired precision, but normal retention, of auditory sensory(‘echoic’) memory information in schizophrenia.J AbnormPsychol106: 315-324.
43. Jaaskealainen IP, Lehtokoski A, Alho K, Kujala T, Pekkonen E, Sinclair JD, Naatanen R, Sillanaukee P (1995a). Low dose ofethanol suppresses mismatch negativity of auditory event-related potentials.Alcoholism ClinExp Res19: 607-610.
44. Jaaskealainen IP, Pekkonen E, Alho K, Sinclair JD, Sillanaukee P, Naatanen R (1995b). Dose-related effect of alcohol on mismatchnegativity and reaction time performance.Alcohol12: 491-495.
45. Jaaskealainen IP, Pekkonen E, Hirvonen J, Sillanaukee P, Naatanen R (1996). Mismatch negativity subcomponents and ethyl alcohol.BiolPsychol43: 13-25.
46. Juckel G, Hegerl U, Molnar M, Cs V, Karmos G (1999). Auditory evoked potentials reflect serotonergic neuronal activity: A studyin behaving cats administered drugs acting on 5-HT1Aautoreceptors in the dorsal raphe nucleus.Neuropsychopharmacology21: 710-716.
47. Juckel G, Molnar M, Hegerl U, Cs V, Karmos G (1997). Auditory-evoked potentials as indicator of brain serotonergic activity: first evidence in behaving cats.Biol Psychiatry41: 1181-1195.
48. Kegeles LS, Abi-Dargham A, Zea-Ponce Y, Rodenhiser-Hill J, Mann JJ, Van Heertum RLet al(2000). Modulation of amphetamine-induced striatal dopamine release by ketamine in humans:implications for schizophrenia.Biol Psychiatry48: 627-640.
49. Korzyukov O, Alho K, Kujala A, Gumenyuk V, Ilmoniemi RJ, Virtanen Jet al(1999). Electromagnetic responses of the humanauditory cortex generated by sensory-memory based processingof tone-frequency changes.Neurosci Lett 276: 169-172.
50. Kreitschmann-Andermahr I, Rosburg T, Demme U, Gaser E, Nowak H, Sauer H (2001). Effect of ketamine on theneuromagnetic mismatch field in healthy humans.Brain ResCogn Brain Res12: 109-116.
51. Kreitschmann-Andermahr I, Rosburg T, Meier T, Volz HP, Nowak H, Sauer H (1999). Impaired sensory processing in male patientswith schizophrenia: a magnetoencephalographic study ofauditory mismatch detection.Schizophr Res 35: 121-129.
52. Krystal JH, D’Souza DC, Karper LP, Bennett A, Abi-Dargham A, Abi-Saab Det al(1999). Interactive effects of subanestheticketamine and haloperidol in healthy humans.Psychopharmacol-ogy (Berl)145: 193-204.
53. Landau SG, Buchsbaum MS, Carpenter W, Strauss J, Sacks M (1976). Schizophrenia and stimulus intensity control.Arch GenPsychiatry32: 1239-1245.
54. Lu ZL, Williamson SJ, Kaufman L (1992). Behavioral lifetime of human auditory sensory memory predicted by physiologicalmeasures.Science258: 1668-1670.
55. Lucas G, De Deurwaerdere P, Porras G, Spampinato U (2000). Endogenous serotonin enhances the release of dopamine in thestriatum only when nigro-striatal dopaminergic transmission isactivated.Neuropharmacology39: 1984-1995.
56. Lucas G, Spampinato U (2000). Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivodopamine outflow in the rat striatum.J Neurochem74: 693-701.
57. McKenna DJ, Repke DB, Lo L, Peroutka SJ (1990).Differential interactions of indolealkylamines with 5-hydroxytryptaminereceptor subtypes.Neuropharmacology29: 193-198.
58. Meltzer HY, McGurk SR (1999). The effects of clozapine, risperidone, and olanzapine on cognitive function in schizo-phrenia.Schizophr Bull25: 233-255.
59. Moghaddam B, Adams B, Verma A, Daly D (1997). Activation of glutamatergic neurotransmission by ketamine: a novel step inthe pathway from NMDA receptor blockade to dopaminergicand cognitive disruptions associated with the prefrontal cortex.JNeurosci17: 2921-2927.
60. Moghaddam B, Adams BW (1998). Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist inrats.Science281: 1349-1352.
61. Naatanen R (1990). The role of attention in auditory information processing as revealed by event-related potentials and otherbrain measures of cognitive function.Behav Brain Sci13:201-288.
62. Naatanen R (1992).Attention and Brain Function.Lawrence Erlbaum Associates: Hillsdale, NJ.
63. Naatanen R (1995). The mismatch negativity: a powerful tool for cognitive neuroscience.Ear Hear16: 6-18.
64. Naatanen R, Alho K (1995a). Generators of electrical and magnetic mismatch responses in humans.Brain Topogr7: 315-320.
65. Naatanen R, Alho K (1995b). Mismatch negativity to change in complex spectrotemporal sound pattern: a new way to studyneural learning in the human brain.ElectroencephalogrClinNeurophysiol44(Suppl): 179-184.
66. Naatanen R, Paavilainen P, Tiitinen H, Jiang D, Alho K (1993). Attention and mismatch negativity.Psychophysiology30:436-450.
67. Naatanen R, Winkler I (1999). The concept of auditory stimulus representation in cognitive neuroscience.Psychol Bull125:826-859.
68. Novak GP, Ritter W, Vaughan HG, Wiznitzer ML (1990).Differentiation of negative event-related potentials in anauditory discrimination task.ElectroencephalogrClinNeurophy-siol75: 255-275.
69. Oades RD, Dittmann-Balcar A, Zerbin D, Grzella I (1997). Impaired attention-dependent augmentation of MMN in nonparanoidvs paranoid schizophrenic patients: a comparison withobsessive-compulsive disorder and healthy subjects.BiolPsy-chiatry41: 1196-1210.
70. Pang EW, Fowler B (1999). Dissociation of the mismatch negativity and processing negativity attentional waveforms with nitrousoxide.Psychophysiology36: 552-558.
71. Pantelis C, Nelson HE, Barnes TRE (1998). Schizophrenia: A Neuropsychological Perspective. 1st edn. John Wiley and Sons:New York.
72. Park S, Holzman PS (1992). Schizophrenics show spatial working memory deficits.Arch Gen Psychiatry49: 975-982.
73. Perris C, Gottfries CG, von Knorring L (1979). Visual averaged evoked responses in psychiatric patients: relationship to levels of5-hydroxy-indoleacetic acid, homovanilic acid and tryptophanin cerebrospinal fluid.J Psychiatr Res15: 175-181.
74. Purdon SE, Jones BD, Stip E, Labelle A, Addington D, David SRet al(2000). Neuropsychological change in early phaseschizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia.Arch Gen Psychiatry57:249-258.
75. Rabinowicz EF, Silipo G, Goldman R, Javitt DC (2000).Auditory sensory dysfunction in schizophrenia.Arch Gen Psychiatry57:1149-1155.
76. Ritter W, Deacon D, Gomes H, Javitt DC, Vaughan Jr HG (1995). The mismatch negativity of event-related potentials as a probe oftransient auditory memory: a review.Ear Hear16: 52-67.
77. Roth WT, Goodale J, Pfefferbaum A (1991). Auditory event-related potentials and electrodermal activity in medicated and unmedi-cated schizophrenics.Biol Psychiatry29: 585-599.
78. Saykin AJ, Shtasel DL, Gur RE, Kester DB, Mozley LH, Stafiniak P, Gur RC (1994). Neuropsychological deficits in neuroleptic naivepatients with first-episode schizophrenia.Arch Gen Psychiatry51: 124-131.
79. Schall U, Catts SV, Chaturvedi S, Liebert B, Redenbach J, Karayanidis F, Ward PB (1998). The effect of clozapine therapyon frontal lobe dysfunction in schizophrenia: neuropsychologyand event-related potential measures.Int J Neuropsychopharma-col1: 19-29.
80. Schooler C, Buchsbaum MS, Carpenter W (1976). Evoked response and kinesthetic measures of augmenting/reducing in schizophrenics: replications and extensions.J NervMent Dis163:221-232.
81. Schr E (1997). On the detection of auditory deviations: a pre-attentive activation model.Psychophysiology34: 245-257.
82. Servan-Schreiber D, Cohen JD, Steingard S (1996).Schizophrenic deficits in the processing of context.A test of a theoreticalmodel.Arch Gen Psychiatry53: 1105-1112.
83. Shelley AM, Ward PB, Catts SV, Michie PT, Andrews S, McConaghy N (1991). Mismatch negativity: an index of apreattentive processing deficit in schizophrenia.Biol Psychiatry30: 1059-1062.
84. Shutara Y, Koga Y, Fujita K, Takeuchi H, Mochida M, Takemasa K (1996). An event-related potential study on the impairment ofautomatic processing of auditory input in schizophrenia.BrainTopogr8: 285-289.
85. Snodgrass JG, Corwin J (1988). Pragmatics of measuring recogni-tion memory: applications to dementia and amnesia.J ExpPsychol117: 34-50.
86. Stip E, Lussier I (1996). The effect of risperidone on cognition in patients with schizophrenia.Can J Psychiatry41(Suppl 2):S35-S40.
87. Strous RD, Cowan N, Ritter W, Javitt DC (1995). Auditory sensory (‘echoic’) memory dysfunction in schizophrenia.Am J Psychiatry152: 1517-1519.
88. Takahata R, Moghaddam B (1998). Glutamatergic regulation of basal and stimulus-activated dopamine release in the prefrontalcortex.J Neurochem71: 1443-1449.
89. Teng EL, Chui HC (1987). The modified Mini-Mental State (3MS) examination.J Clin Psychiatry48: 314-318.
90. Tewes U (1994). HAWIE-R: Hamburg-Wechsler-Intelligenztest fur Erwachsene, Revision 1991. 2nd edn. Hans Huber AG: Bern.
91. Tiitinen H, Alho K, Huotilainen M, Ilmoniemi RJ, Simola J, Naatanen R (1993). Tonotopic auditory cortex and themagnetoencephalographic (MEG) equivalent of the mismatchnegativity.Psychophysiology30: 537-540.
92. Tuchtenhagen F, Daumann J, Norra C, Gobbele R, Becker S, Pelz Set al(2000). High intensity dependence of auditory evokeddipole source activity indicates decreased serotonergic activity inabstinent ecstasy (MDMA) users.Neuropsychopharmacology22:608-617.
93. Umbricht D, Javitt DC, Novak GP, Bates JA, Pollack S, Lieberman Jet al(1998). Effects of clozapine on auditory event-relatedpotentials in schizophrenia.Biol Psychiatry44: 716-725.
94. Umbricht D, Javitt DC, Novak GP, Bates JA, Pollak S, Lieberman J, Kane J (1999). Effects of risperidone on auditory event-related Potentials in schizophrenia.Int J Neuropsychopharmacol2: 229-304.
95. Umbricht D, Schmid L, Koller R, Vollenweider FX, Hell D, Javitt DC (2000). Ketamine-induced deficits in auditory and visualcontext-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.Arch GenPsychiatry57: 1139-1147.
96. Vollenweider FX (1998). Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble toschizophrenia research.Pharmacopsychiatry31(Suppl 2): 92-103.
97. Vollenweider FX, Leenders KL, Scharfetter C, Maguire P, Stadelmann O, Angst J (1997). Positron emission tomographyand fluorodeoxyglucose studies of metabolic hyperfrontality andpsychopathology in the psilocybin model of psychosis.Neurop-sychopharmacology16: 357-372.
98. Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Babler A, Vogel H, Hell D (1998). Psilocybin induces schizophrenia-likepsychosis in humans via a serotonin-2 agonist action.Neurore-port9: 3897-3902.
99. Vollenweider FX, Vontobel P, Hell D, Leenders KL (1999). HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man: a PET study with [11C]raclopride.Neuropsychopharmacology20: 424-433.
100. Vollenweider FX, Vontobel P, Oye I, Hell D, Leenders KL (2000). Effects of (S)-ketamine on striatal dopamine: a [nC]raclopridePET study of a model psychosis in humans.J Psychiatr Res34:35-43.
101. vonKnorring L, Perris C (1981). Biochemistry of the augmenting-reducing response in visual evoked potentials.Neuropsychobiol-ogy7: 1-8.
102. Wang W, Timsit-Berthier M, Schoenen J (1996). Intensity dependence of auditory evoked potentials is pronounced inmigraine: an indication of cortical potentiation and lowserotonergic neurotransmission?Neurology46: 1404-1409.
103. Wexler BE, Stevens AA, Bowers AA, Sernyak MJ, Goldman-Rakic PS (1998). Word and tone working memory deficits inschizophrenia.Arch Gen Psychiatry55: 1093-1096.
104. Wittchen H, Semler G (1996).Composite International Diagnostic Interview (CIDI). Germany, Beltz-Test, GmbH, PsychologieVerlags Union: Weinheim.
105. Woerner MG, Manuzza S, Kane JM (1988). Anchoring the Brief Psychiatric Rating Scale: an aid to improve reliability.Psycho-pharmacol Bull24: 112-117.
106. Yan QS (2000). Activation of 5-HT2A/2Creceptors within the nucleus accumbens increases local dopaminergic transmission.Brain Res Bull51: 75-81.